slider-1-back

About the Centre

Harnessing world leading science to cure cancer

Find out more about us
bokeh-slider-background

Research

We have achieved a critical mass of investment here in Oxford and the opportunities for cancer research are immense

Find out more...

funding-slider-background

Funding

The Centre supports researchers at every stage of their career and are committed to facilitating more excellent science in Oxford

Learn about our funding

Cancer Research UK Oxford Centre Announces Prof. Xin Lu as New Co-Director

The Centre is pleased to announce the appointment of Professor Xin Lu as Co-Director of the Centre.

Simon Leedham awarded the Cancer Research UK Future Leaders in Cancer Research Prize

Today at the NCRI Annual Conference Professor Simon Leedham was…

Oxford University scientist developing new treatments to tackle breast cancer that has spread to the brain

Professor Nicola Sibson of the Department of Oncology has been awarded a grant worth almost £200,000 by research charity Breast Cancer Now to fund cutting-edge research to uncover novel treatment combinations to control breast cancer that has spread to the brain.

John Findlay wins Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS) Prize

John Findlay wins Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS) prize for his presentation ’Staging gastric cancer with 18F-FDG PET-CT identifies frequent unsuspected metastases and patients of high risk of incurable disease, early recurrence and death’

From bench to bedside in two years: collaborative science opens the way for a new drug for bowel cancer patients across the UK

Today a new drug will become available for patients with bowel cancer as part of a national clinical trial; based on a scientific discovery made only two years ago at the University of Oxford.

Researchers Make Breakthrough Discovery in Fight against Colorectal Cancer

Professor Tim Maughan, Professor of Clinical Oncology at the University of Oxford and Principal Lead of the S:CORT Consortium said: “This research emphasises how a collaborative approach can give significant insight into bowel cancer disease biology, but also to begin to translate this knowledge into clinically-relevant applications. As part of the work of the S:CORT consortium, we will now focus on making sure that the research is put into practice so that it can become part of the standard of care for patients.”

FOXFIRE Combined Analysis Update

FOXFIRE Combined Analysis indicates no benefit in overall survival from adding selective internal radiotherapy [SIRT] to first-line oxaliplatin-based chemotherapy for metastatic colorectal cancer. Secondary analyses confirm improved control of liver metastases with liver-directed SIRT and show clinical benefit in patients with liver metastases originating from difficult-to-treat right-sided colon cancer.

New Era in Precision Medicine for Pancreatic Cancer

The development of new treatments for pancreatic cancer is set to be transformed by a network of clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research UK today.
Preclinical validation lab

Radiotherapy risks are much higher for smokers

Smokers treated for breast cancer have much higher risks than non-smokers of developing lung cancer or heart attack as a result of radiotherapy – according to a new study lead by the University of Oxford published in the Journal of Clinical Oncology.

Tweets

Oxford Centre Films

Find out more about the Early Phase Clinical Trials Unit in Oxford:

CRUK International Symposium on Oesophageal Cancer highlights:

Professor Nicola Sibson discusses her research into mapping brain tumours:

Development fund

Funding

The Centre supports researchers at every stage of their career and are committed to facilitating more excellent science in Oxford.

Resources

Resources

We have achieved a critical mass of investment here in Oxford and the opportunities for cancer research are immense.

DPhil

Graduate studies

Oxford University is first and foremost an institution dedicated to education and is consistently the world’s best university for clinical, pre-clinical and health training. It is within this enriched environment that the Centre is able to implement its strategy for training the next generation of cancer researchers.

OCRC symposium

Events

Through our networking and events programme, the Centre brings together the individual components of the Centre into a cohesive community for cancer research.

Get in touch

Got a Question? Want to learn more about the Centre? Please contact us!

You can also find the centre and get direction using our location page.